Pharmaceuticals · Recorded milestone
Alzheimer's-slowing antibodies
Recorded year2023
Lecanemab is fully approved to slow early Alzheimer's disease.
Explore this milestone on the interactive mapBuilt on
Led to
Sources & evidence
Dataset updated 2026-10-18. This individual record has not been separately re-reviewed.